Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide for COVID-19 Respiratory Distress
NCT04348383Phase 2Completed
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Apr 2020
- Primary completion
- Feb 2023
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of defibrotide in coronavirus disease 2019 (COVID-19), sponsored by Fundación para la Formación e Investigación Sanitaria. Started Apr 2020; status: completed.
02
Drugs
defibrotide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04348383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348383.